Genedx Holdings (NASDAQ: WGS) reported Q4 2023 earnings per share (EPS) of -$0.92, up 96.82% year over year. Total Genedx Holdings earnings for the quarter were -$25.77 million. In the same quarter last year, Genedx Holdings's earnings per share (EPS) was -$28.97.
As of Q2 2024, Genedx Holdings's earnings has grown year over year. Genedx Holdings's earnings in the past year totalled -$175.77 million.
What is WGS's earnings date?
Genedx Holdings's earnings date is Invalid Date. Add WGS to your watchlist to be reminded of WGS's next earnings announcement.
What was WGS's revenue last quarter?
Genedx Holdings (NASDAQ: WGS) reported Q4 2023 revenue of $57.42 million up 6.41% year over year. In the same quarter last year, Genedx Holdings's revenue was $61.35 million.
What was WGS's revenue growth in the past year?
As of Q2 2024, Genedx Holdings's revenue has grown -13.69% year over year. This is 25.67 percentage points lower than the US Health Information Services industry revenue growth rate of 11.98%. Genedx Holdings's revenue in the past year totalled $202.57 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.